LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has given effect to the issuance of duplicate share certificate in lieu of lost / misplaced share certificate. LYKA LABS LTD. - 500259 - Notice Of Extra Ordinary General Meeting Of The Company To Be Held On 17Th February 2023
In continuation to earlier communication on 21st January 2023, Notice of Extra Ordinary General Meeting is attached herewith of the Company to be held on Friday, 17th February 2023 at 11:00 a.m. through Video Conferencing (VC)/Other Video Visual Means (OAVM). LYKA LABS LTD. - 500259 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 21St January 2023
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; this is to inform you that the Board of Directors at its Meeting held today i.e.21st January 2023 inter alia transacted the following; 1. Issue of Equity Shares and Warrants convertible into Equity Shares on preferential basis to Promoter Group 2. Convening of Extra Ordinary General Meeting (EOGM) of the Company LYKA LABS LTD. - 500259 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 21St January 2023.
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2023 ,inter alia, to consider and approve A meeting of the Board of Directors of the Company is schedule to be held on Saturday, 21st January, 2023 at the Corporate Office of the Company inter alia to consider and evaluate proposal for raising of funds by way of issue of equity shares or any other eligible convertible securities, through permissible modes or combination of both, subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; we wish to inform you that the Company has received an intimation from M/s. Link Intime India Private Limited ('Registrar and Share Transfer Agent' of the Company) pertaining to loss of share certificates. LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018; enclosing herewith a certificate for the quarter ended 31st December 2022, as received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has received an intimation from M/s. Link Intime India Private Limited ('Registrar and Share Transfer Agent' of the Company) pertaining to loss of share certificates. Kindly take the same on your record. LYKA LABS LTD. - 500259 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of SEBI Insider Trading) Regulation, 2015; the trading window for dealing in securities of the Company shall remain closed with effect from 1st January 2023 till 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2022; for 'Designated Persons' of the Company including their immediate relatives. LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; the Company has received an intimation from M/s. Link Intime India Private Limited ('Registrar and Share Transfer Agent' of the Company) pertaining to loss of share certificates. Further, the Company has also intimated about giving effect to the issuance of duplicate share certificate. LYKA LABS LTD. - 500259 - Updates On Acquisition Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
Please refer to our earlier communication dated 9th November 2022, with reference to the proposed acquisition of animal healthcare business from Agilis Healthcare Private Limited. Now we further wish to inform you that today the Company has finalised and signed the agreement with the Agilis Healthcare Private Limited as per the above referred disclosure. Kindly take the note of the above information on your record.